Weekly shot vs daily injection: race to stop bleeding after transplant
NCT ID NCT07400341
Summary
This study is for adults with MDS or aplastic anemia who receive a donor stem cell transplant. After transplant, patients often struggle with low platelets, which increases bleeding risk. Researchers are comparing a once-weekly injection (romiplostim) against a daily injection (rhTPO) to see which helps platelets recover faster and more safely. About 66 participants will be randomly assigned to one of the two treatments, which start a few days after transplant and continue for up to 8 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MDS (MYELODYSPLASTIC SYNDROME) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Soochow University, Department of Hematology
Suzhou, Jiangsu, 215006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.